TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06455280 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT06501183 — Predictive Biomarker (PRD): CDH17 mRNA
Genes: CDH17
Study NCT05818007 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05802836 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT06569329 — Surrogate Endpoint (SUR): Bacterial count
Study NCT06190275 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05450029 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05579522 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05414149 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05218577 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06096428 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT06268418 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04725188 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06325852 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT06518837 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06518837 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06518837 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06518837 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04967001 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04957082 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05242978 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06570915 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06543381 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05536154 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05536154 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05593497 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT06302621 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05838547 — Predictive Biomarker (PRD): NPR3 mRNA
Genes: NPR3; ANPRC; C5orf23; NPRC
Study NCT06645600 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06059846 — Predictive Biomarker (PRD): TBP mRNA
Genes: TBP; GTF2D1; TF2D; TFIID
Study NCT06136884 — Predictive Biomarker (PRD): TACC3 mRNA
Genes: TACC3; ERIC1
Study NCT06137664 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05378763 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05378763 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06420063 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT04309500 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT04309500 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04309500 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05212337 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06678581 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT06679543 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06682000 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06690723 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT06690723 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06690723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06690723 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT06694129 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06691152 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06690372 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study NCT06504966 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06439771 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06439771 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06439771 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT05725655 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06015568 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06501248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04739215 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05862480 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05947422 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04749563 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study NCT06632860 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT05759546 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05759546 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05759546 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04853589 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06555029 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05200429 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06563674 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06333158 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05444933 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05444933 — Predictive Biomarker (PRD): VEGF
Genes: VEGFA; VEGF-A; VPF
Study NCT05444933 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05197270 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05197270 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05676450 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06133270 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT05313958 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05331807 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05331807 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06277583 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06443593 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05783349 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT05428007 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05069740 — Predictive Biomarker (PRD): LOX mRNA
Genes: LOX
Study NCT05069740 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05289908 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05360602 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT05360602 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study NCT04753463 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04976296 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05466071 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05466071 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04856371 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04856371 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04856371 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04856371 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04856371 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04856371 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04856371 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06671392 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05003141 — Predictive Biomarker (PRD): CD37 mRNA
Genes: CD37; TSPAN26
Study NCT06681012 — Predictive Biomarker (PRD): XG mRNA
Genes: XG; PBDX
Study NCT06689527 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06687733 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05965479 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05954494 — Predictive Biomarker (PRD): WDR45 mRNA
Genes: WDR45; WDRX1; WDRXI4; WIPI4; JM5
Study NCT06686576 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06065904 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06438250 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05142319 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06177431 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT05504083 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT06570031 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06570031 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06570031 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03841474 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03841474 — Safety Biomarker (SAF): BDNF
Study NCT04925089 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05869643 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05169944 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05169944 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study NCT06100276 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT06100276 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06435858 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06377228 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05906992 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00002011 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT02942706 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02942706 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT02942706 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02942706 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04944381 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06057610 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04807400 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04807400 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06161857 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT06508437 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06508437 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06508437 — Safety Biomarker (SAF): Interleukin 1
Study NCT06508437 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05564676 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05564676 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05253651 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05211609 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT04505878 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT06499961 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06499961 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05731544 — Predictive Biomarker (PRD): BMF mRNA
Genes: BMF
Study NCT05081271 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05852990 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06599320 — Predictive Biomarker (PRD): SLA mRNA
Genes: SLA; SLAP; SLAP1
Study NCT05336357 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06670677 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06674343 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06687421 — Predictive Biomarker (PRD): LRIT1 mRNA
Genes: LRIT1; LRRC21; PAL
Study NCT05453448 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01258426 — Predictive Biomarker (PRD): SELENOP mRNA
Genes: SELENOP; SELP; SEPP1
Study NCT01442571 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05044039 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05592743 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05592743 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT05811013 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05811013 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT06076772 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06076772 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06255626 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT06569420 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06570226 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06570928 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05488795 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06045286 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00671242 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00671242 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00671242 — Predictive Biomarker (PRD): SLC7A5 mRNA
Genes: SLC7A5; CD98LC; LAT1; MPE16
Study NCT00671242 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT05832541 — Predictive Biomarker (PRD): ZEB2 mRNA
Genes: ZEB2; KIAA0569; SIP1; ZFHX1B; ZFX1B; HRIHFB2411
Study NCT05832541 — Predictive Biomarker (PRD): TWIST1 mRNA
Genes: TWIST1; BHLHA38; TWIST
Study NCT05957094 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06527209 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT05247866 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT06640504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06640504 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06640504 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06641024 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06577441 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT05960201 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT04726956 — Predictive Biomarker (PRD): AKR1B10 mRNA
Genes: AKR1B10; AKR1B11
Study NCT05842850 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study NCT04893109 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06538181 — Predictive Biomarker (PRD): UBA1 mRNA
Genes: UBA1; A1S9T; UBE1
Study NCT06538181 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06538181 — Predictive Biomarker (PRD): IRAK1 mRNA
Genes: IRAK1; IRAK
Study NCT04858997 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04858997 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04858997 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04858997 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05339425 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04896931 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT06475495 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06569511 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05753228 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT05008133 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06285357 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06474962 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05885048 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04402073 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study NCT06324539 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT06643013 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT05735847 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05735847 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05306353 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT05306353 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05558085 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05333588 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06672822 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT05161403 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04888364 — Predictive Biomarker (PRD): GNL3 mRNA
Genes: GNL3; E2IG3; NS
Study NCT06674070 — Predictive Biomarker (PRD): SCN2A mRNA
Genes: SCN2A; NAC2; SCN2A1; SCN2A2
Study NCT06674070 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT06673485 — Surrogate Endpoint (SUR): Serum calcium
Study NCT06688656 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06632873 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT06632873 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06099353 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06099353 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06099353 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06057025 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06413069 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06004583 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05245058 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05310357 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05538858 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05538858 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04412070 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05540184 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06511648 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT06641622 — Predictive Biomarker (PRD): CIRBP mRNA
Genes: CIRBP; A18HNRNP; CIRP
Study NCT06636903 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05745948 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05501522 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05804084 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05109559 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06024538 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03733535 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05629572 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT06410131 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT06410131 — Predictive Biomarker (PRD): TPBG mRNA
Genes: TPBG; 5T4
Study NCT05682443 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05682443 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04972604 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04972604 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT05593770 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT05976477 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06642623 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06641453 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT06644950 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05516472 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT06113367 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06113367 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06428188 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06428188 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06642948 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06326541 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06640764 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study NCT06675123 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06675123 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06679283 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06679283 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04837196 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT05063136 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05063136 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL